Loading…

Prospective investigation of second-trimester thrombin activation and preterm birth

Objective We sought to determine if second-trimester amniotic fluid thrombin-antithrombin (TAT) complexes concentration correlates with subsequent preterm birth. Study Design A cohort of 550 women with singleton nonanomalous pregnancies undergoing second-trimester genetic amniocentesis was followed...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2012-04, Vol.206 (4), p.333.e1-333.e6
Main Authors: Vidaeff, Alex C., MD, MPH, Monga, Manju, MD, Saade, George, MD, Bishop, Karen, BS, Ramin, Susan M., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423
cites cdi_FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423
container_end_page 333.e6
container_issue 4
container_start_page 333.e1
container_title American journal of obstetrics and gynecology
container_volume 206
creator Vidaeff, Alex C., MD, MPH
Monga, Manju, MD
Saade, George, MD
Bishop, Karen, BS
Ramin, Susan M., MD
description Objective We sought to determine if second-trimester amniotic fluid thrombin-antithrombin (TAT) complexes concentration correlates with subsequent preterm birth. Study Design A cohort of 550 women with singleton nonanomalous pregnancies undergoing second-trimester genetic amniocentesis was followed up to delivery and analyzed as a nested case-control study. Cases of preterm birth (n = 52) were compared with 104 term control subjects. Amniotic fluid collected at amniocentesis was tested for TAT. Results TAT concentrations were significantly higher in women who delivered preterm (median 115.9 µg/L) than in those who did not (median 62.2 µg/L; P < .001). This difference persisted when 31 spontaneous preterm births and 21 indicated preterm births were analyzed separately. The odds ratios for preterm birth in the highest TAT quartile relative to the lowest quartile was 4.98 (95% confidence interval, 1.17–22.01; P = .007). Conclusion We found a difference in the pattern of intraamniotic thrombin generation between women destined to deliver at term and those who deliver preterm, regardless of the type of preterm birth.
doi_str_mv 10.1016/j.ajog.2012.02.010
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_963836921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002937812001573</els_id><sourcerecordid>963836921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423</originalsourceid><addsrcrecordid>eNp9kd-L1DAQx4Mo3nr6D_ggfRGfus4kaZuACHL4Cw4UTp9Dmk7vUrvJmnQX7r83ZVcFHwwDIcznO5n5DmPPEbYI2L6etnaKt1sOyLdQAuEB2yDorm5Vqx6yDQDwWotOXbAnOU_rk2v-mF1wLlsJXbdhN19TzHtyiz9S5cOR8uJv7eJjqOJYZXIxDPWS_K4kKFXLXYq73ofKrooTZ8NQ7ROV9K7qfVrunrJHo50zPTvfl-z7h_ffrj7V118-fr56d107KWGpUWtU0kKrQMuGei7QaadQNNCQkGRbpZtylBobqdHqEVBzPgrUPR8lF5fs1anuPsWfh9Kg2fnsaJ5toHjIRrdCiVZzLCQ_ka5MmxONZl9GsuneIJjVSzOZ1UuzemmgBEIRvTiXP_Q7Gv5IfptXgJdnwGZn5zHZ4Hz-yzWdkqprC_fmxFEx4-gpmew8BUeDT8V5M0T__z7e_iN3sw--_PiD7ilP8ZBCsdmgyUVgbtY1r0tHDoBNJ8QvZ1-mPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>963836921</pqid></control><display><type>article</type><title>Prospective investigation of second-trimester thrombin activation and preterm birth</title><source>Elsevier</source><creator>Vidaeff, Alex C., MD, MPH ; Monga, Manju, MD ; Saade, George, MD ; Bishop, Karen, BS ; Ramin, Susan M., MD</creator><creatorcontrib>Vidaeff, Alex C., MD, MPH ; Monga, Manju, MD ; Saade, George, MD ; Bishop, Karen, BS ; Ramin, Susan M., MD</creatorcontrib><description>Objective We sought to determine if second-trimester amniotic fluid thrombin-antithrombin (TAT) complexes concentration correlates with subsequent preterm birth. Study Design A cohort of 550 women with singleton nonanomalous pregnancies undergoing second-trimester genetic amniocentesis was followed up to delivery and analyzed as a nested case-control study. Cases of preterm birth (n = 52) were compared with 104 term control subjects. Amniotic fluid collected at amniocentesis was tested for TAT. Results TAT concentrations were significantly higher in women who delivered preterm (median 115.9 µg/L) than in those who did not (median 62.2 µg/L; P &lt; .001). This difference persisted when 31 spontaneous preterm births and 21 indicated preterm births were analyzed separately. The odds ratios for preterm birth in the highest TAT quartile relative to the lowest quartile was 4.98 (95% confidence interval, 1.17–22.01; P = .007). Conclusion We found a difference in the pattern of intraamniotic thrombin generation between women destined to deliver at term and those who deliver preterm, regardless of the type of preterm birth.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2012.02.010</identifier><identifier>PMID: 22464077</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Amniocentesis ; amniotic fluid ; Amniotic Fluid - chemistry ; Antithrombin III - analysis ; Antithrombin III - biosynthesis ; Biological and medical sciences ; Case-Control Studies ; Diseases of mother, fetus and pregnancy ; Enzyme Activation ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Obstetrics and Gynecology ; Peptide Hydrolases - analysis ; Peptide Hydrolases - biosynthesis ; Pregnancy ; Pregnancy Trimester, Second - blood ; Pregnancy. Fetus. Placenta ; Premature Birth ; preterm birth ; Prospective Studies ; Thrombin - analysis ; Thrombin - biosynthesis ; thrombin-antithrombin complexes</subject><ispartof>American journal of obstetrics and gynecology, 2012-04, Vol.206 (4), p.333.e1-333.e6</ispartof><rights>Mosby, Inc.</rights><rights>2012 Mosby, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423</citedby><cites>FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25784876$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22464077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vidaeff, Alex C., MD, MPH</creatorcontrib><creatorcontrib>Monga, Manju, MD</creatorcontrib><creatorcontrib>Saade, George, MD</creatorcontrib><creatorcontrib>Bishop, Karen, BS</creatorcontrib><creatorcontrib>Ramin, Susan M., MD</creatorcontrib><title>Prospective investigation of second-trimester thrombin activation and preterm birth</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective We sought to determine if second-trimester amniotic fluid thrombin-antithrombin (TAT) complexes concentration correlates with subsequent preterm birth. Study Design A cohort of 550 women with singleton nonanomalous pregnancies undergoing second-trimester genetic amniocentesis was followed up to delivery and analyzed as a nested case-control study. Cases of preterm birth (n = 52) were compared with 104 term control subjects. Amniotic fluid collected at amniocentesis was tested for TAT. Results TAT concentrations were significantly higher in women who delivered preterm (median 115.9 µg/L) than in those who did not (median 62.2 µg/L; P &lt; .001). This difference persisted when 31 spontaneous preterm births and 21 indicated preterm births were analyzed separately. The odds ratios for preterm birth in the highest TAT quartile relative to the lowest quartile was 4.98 (95% confidence interval, 1.17–22.01; P = .007). Conclusion We found a difference in the pattern of intraamniotic thrombin generation between women destined to deliver at term and those who deliver preterm, regardless of the type of preterm birth.</description><subject>Adult</subject><subject>Amniocentesis</subject><subject>amniotic fluid</subject><subject>Amniotic Fluid - chemistry</subject><subject>Antithrombin III - analysis</subject><subject>Antithrombin III - biosynthesis</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Enzyme Activation</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Obstetrics and Gynecology</subject><subject>Peptide Hydrolases - analysis</subject><subject>Peptide Hydrolases - biosynthesis</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, Second - blood</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Premature Birth</subject><subject>preterm birth</subject><subject>Prospective Studies</subject><subject>Thrombin - analysis</subject><subject>Thrombin - biosynthesis</subject><subject>thrombin-antithrombin complexes</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kd-L1DAQx4Mo3nr6D_ggfRGfus4kaZuACHL4Cw4UTp9Dmk7vUrvJmnQX7r83ZVcFHwwDIcznO5n5DmPPEbYI2L6etnaKt1sOyLdQAuEB2yDorm5Vqx6yDQDwWotOXbAnOU_rk2v-mF1wLlsJXbdhN19TzHtyiz9S5cOR8uJv7eJjqOJYZXIxDPWS_K4kKFXLXYq73ofKrooTZ8NQ7ROV9K7qfVrunrJHo50zPTvfl-z7h_ffrj7V118-fr56d107KWGpUWtU0kKrQMuGei7QaadQNNCQkGRbpZtylBobqdHqEVBzPgrUPR8lF5fs1anuPsWfh9Kg2fnsaJ5toHjIRrdCiVZzLCQ_ka5MmxONZl9GsuneIJjVSzOZ1UuzemmgBEIRvTiXP_Q7Gv5IfptXgJdnwGZn5zHZ4Hz-yzWdkqprC_fmxFEx4-gpmew8BUeDT8V5M0T__z7e_iN3sw--_PiD7ilP8ZBCsdmgyUVgbtY1r0tHDoBNJ8QvZ1-mPw</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Vidaeff, Alex C., MD, MPH</creator><creator>Monga, Manju, MD</creator><creator>Saade, George, MD</creator><creator>Bishop, Karen, BS</creator><creator>Ramin, Susan M., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Prospective investigation of second-trimester thrombin activation and preterm birth</title><author>Vidaeff, Alex C., MD, MPH ; Monga, Manju, MD ; Saade, George, MD ; Bishop, Karen, BS ; Ramin, Susan M., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Amniocentesis</topic><topic>amniotic fluid</topic><topic>Amniotic Fluid - chemistry</topic><topic>Antithrombin III - analysis</topic><topic>Antithrombin III - biosynthesis</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Enzyme Activation</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Obstetrics and Gynecology</topic><topic>Peptide Hydrolases - analysis</topic><topic>Peptide Hydrolases - biosynthesis</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, Second - blood</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Premature Birth</topic><topic>preterm birth</topic><topic>Prospective Studies</topic><topic>Thrombin - analysis</topic><topic>Thrombin - biosynthesis</topic><topic>thrombin-antithrombin complexes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vidaeff, Alex C., MD, MPH</creatorcontrib><creatorcontrib>Monga, Manju, MD</creatorcontrib><creatorcontrib>Saade, George, MD</creatorcontrib><creatorcontrib>Bishop, Karen, BS</creatorcontrib><creatorcontrib>Ramin, Susan M., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vidaeff, Alex C., MD, MPH</au><au>Monga, Manju, MD</au><au>Saade, George, MD</au><au>Bishop, Karen, BS</au><au>Ramin, Susan M., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective investigation of second-trimester thrombin activation and preterm birth</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>206</volume><issue>4</issue><spage>333.e1</spage><epage>333.e6</epage><pages>333.e1-333.e6</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Objective We sought to determine if second-trimester amniotic fluid thrombin-antithrombin (TAT) complexes concentration correlates with subsequent preterm birth. Study Design A cohort of 550 women with singleton nonanomalous pregnancies undergoing second-trimester genetic amniocentesis was followed up to delivery and analyzed as a nested case-control study. Cases of preterm birth (n = 52) were compared with 104 term control subjects. Amniotic fluid collected at amniocentesis was tested for TAT. Results TAT concentrations were significantly higher in women who delivered preterm (median 115.9 µg/L) than in those who did not (median 62.2 µg/L; P &lt; .001). This difference persisted when 31 spontaneous preterm births and 21 indicated preterm births were analyzed separately. The odds ratios for preterm birth in the highest TAT quartile relative to the lowest quartile was 4.98 (95% confidence interval, 1.17–22.01; P = .007). Conclusion We found a difference in the pattern of intraamniotic thrombin generation between women destined to deliver at term and those who deliver preterm, regardless of the type of preterm birth.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>22464077</pmid><doi>10.1016/j.ajog.2012.02.010</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2012-04, Vol.206 (4), p.333.e1-333.e6
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_963836921
source Elsevier
subjects Adult
Amniocentesis
amniotic fluid
Amniotic Fluid - chemistry
Antithrombin III - analysis
Antithrombin III - biosynthesis
Biological and medical sciences
Case-Control Studies
Diseases of mother, fetus and pregnancy
Enzyme Activation
Female
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Obstetrics and Gynecology
Peptide Hydrolases - analysis
Peptide Hydrolases - biosynthesis
Pregnancy
Pregnancy Trimester, Second - blood
Pregnancy. Fetus. Placenta
Premature Birth
preterm birth
Prospective Studies
Thrombin - analysis
Thrombin - biosynthesis
thrombin-antithrombin complexes
title Prospective investigation of second-trimester thrombin activation and preterm birth
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A59%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20investigation%20of%20second-trimester%20thrombin%20activation%20and%20preterm%20birth&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Vidaeff,%20Alex%20C.,%20MD,%20MPH&rft.date=2012-04-01&rft.volume=206&rft.issue=4&rft.spage=333.e1&rft.epage=333.e6&rft.pages=333.e1-333.e6&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1016/j.ajog.2012.02.010&rft_dat=%3Cproquest_cross%3E963836921%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-199184a0680945eb231c9c813505e34ea689555588f5491a9f01922f319b2f423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=963836921&rft_id=info:pmid/22464077&rfr_iscdi=true